CD8A and cancer: In addition, FCGR3A expression was associated with CD8+ T cell levels in 25 cancer types, CD4+T cell levels in 28 cancer types, macrophage levels in 27 cancer types, neutrophil levels in 30 cancer types, and dendritic cell (DC) levels in 30 cancer types (Table S2).